ARTICLE | Clinical News
Helixate FS regulatory update
October 17, 2005 7:00 AM UTC
CSL subsidiary ZLB Behring received FDA approval to store Helixate FS at room temperature for 3 months. Previously, the recombinant non-plasma derived Factor VIII to treat hemophilia A required refrig...